Subscribe To
Valneva's covid-19 shot fails as booster in pfizer/biontech vaccinated population
Valneva SE (NASDAQ: VALN) has responded to data published from the U.K COV-Boost COVID-19 vaccine trial that investigated the reactogenicity and im...
December 3, 2021, 1:31 pm
Delcath systems reveals initial survival data from ocular melanoma trial
Delcath Systems Inc (NASDAQ: DCTH) has announced results from the Phase 3 FOCUS study of Hepzato Kit (melphalan hydrochloride for injection/hepatic...
December 2, 2021, 1:27 pm
Delcath systems reveals initial survival data from ocular melanoma trial
Delcath Systems Inc (NASDAQ: DCTH) has announced results from the Phase 3 FOCUS study of Hepzato Kit (melphalan hydrochloride for injection/hepatic...
December 2, 2021, 1:27 pm
Delcath systems reveals initial survival data from ocular melanoma trial
Delcath Systems Inc (NASDAQ: DCTH) has announced results from the Phase 3 FOCUS study of Hepzato Kit (melphalan hydrochloride for injection/hepatic...
December 2, 2021, 1:27 pm
Dr. gottlieb: the vaccines might be sufficient to control spread of new covid variant
Dr. Scott Gottlieb, former FDA commissioner, joins 'Closing Bell' to discuss the new Covid-19 variant. He says if the majority of the ...
November 26, 2021, 1:02 pm
Dr. gottlieb: the vaccines might be sufficient to control spread of new covid variant
Dr. Scott Gottlieb, former FDA commissioner, joins 'Closing Bell' to discuss the new Covid-19 variant. He says if the majority of the ...
November 26, 2021, 1:02 pm
Dr. gottlieb: the vaccines might be sufficient to control spread of new covid variant
Dr. Scott Gottlieb, former FDA commissioner, joins 'Closing Bell' to discuss the new Covid-19 variant. He says if the majority of the ...
November 26, 2021, 1:02 pm
Tabula rasa healthcare inks deal with ascp to offer medwise® to consultant care pharmacists
MOORESTOWN, N.J., Oct. 7, 2021 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® (TRHC) (NASDAQ: TRHC), a leading healthcare technology company advanc...
October 7, 2021, 12:30 pm
Tabula rasa healthcare inks deal with ascp to offer medwise® to consultant care pharmacists
MOORESTOWN, N.J., Oct. 7, 2021 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® (TRHC) (NASDAQ: TRHC), a leading healthcare technology company advanc...
October 7, 2021, 12:30 pm
Tabula rasa healthcare inks deal with ascp to offer medwise® to consultant care pharmacists
MOORESTOWN, N.J., Oct. 7, 2021 /PRNewswire/ -- Tabula Rasa HealthCare, Inc.® (TRHC) (NASDAQ: TRHC), a leading healthcare technology company advanc...
October 7, 2021, 12:30 pm
Cloud dx says canadian study using its technology proves remote patient monitoring improves outcomes
Cloud DX Inc said a national medical study using its Connected Health platform proves remote patient monitoring (RPM) improves patient outcomes. Resu...
October 7, 2021, 9:33 am
Cloud dx says canadian study using its technology proves remote patient monitoring improves outcomes
Cloud DX Inc said a national medical study using its Connected Health platform proves remote patient monitoring (RPM) improves patient outcomes. Resu...
October 7, 2021, 9:33 am
Cloud dx says canadian study using its technology proves remote patient monitoring improves outcomes
Cloud DX Inc said a national medical study using its Connected Health platform proves remote patient monitoring (RPM) improves patient outcomes. Resu...
October 7, 2021, 9:33 am
Is pfizer stock a buy after study reveals the need for booster shots?
On Tuesday, Pfizer Inc. (NYSE:PFE) shares edged slightly higher after The Lancet published a report showing its covid-19 vaccine weakens after six mon...
October 5, 2021, 1:22 pm
Is pfizer stock a buy after study reveals the need for booster shots?
On Tuesday, Pfizer Inc. (NYSE:PFE) shares edged slightly higher after The Lancet published a report showing its covid-19 vaccine weakens after six mon...
October 5, 2021, 1:22 pm
Is pfizer stock a buy after study reveals the need for booster shots?
On Tuesday, Pfizer Inc. (NYSE:PFE) shares edged slightly higher after The Lancet published a report showing its covid-19 vaccine weakens after six mon...
October 5, 2021, 1:22 pm
Is pfizer stock a buy after study reveals the need for booster shots?
On Tuesday, Pfizer Inc. (NYSE:PFE) shares edged slightly higher after The Lancet published a report showing its covid-19 vaccine weakens after six mon...
October 5, 2021, 1:22 pm
Is pfizer stock a buy after study reveals the need for booster shots?
On Tuesday, Pfizer Inc. (NYSE:PFE) shares edged slightly higher after The Lancet published a report showing its covid-19 vaccine weakens after six mon...
October 5, 2021, 1:22 pm
Is pfizer stock a buy after study reveals the need for booster shots?
On Tuesday, Pfizer Inc. (NYSE:PFE) shares edged slightly higher after The Lancet published a report showing its covid-19 vaccine weakens after six mon...
October 5, 2021, 1:22 pm
Is pfizer stock a buy after study reveals the need for booster shots?
On Tuesday, Pfizer Inc. (NYSE:PFE) shares edged slightly higher after The Lancet published a report showing its covid-19 vaccine weakens after six mon...
October 5, 2021, 1:22 pm